Total Payments
$10,950
2024 Payments
$5,759
Companies
38
Transactions
291
Medicare Patients
7,699
Medicare Billing
$2.0M
Payment Breakdown by Category
Food & Beverage$6,659 (60.8%)
Travel$3,485 (31.8%)
Research$792.75 (7.2%)
Education$13.21 (0.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $6,659 | 271 | 60.8% |
| Travel and Lodging | $3,485 | 10 | 31.8% |
| Unspecified | $792.75 | 5 | 7.2% |
| Education | $13.21 | 5 | 0.1% |
Payments by Type
General
$10,158
286 transactions
Research
$792.75
5 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| CSL Behring | $2,066 | 6 | $0 (2024) |
| Medtronic, Inc. | $1,741 | 11 | $0 (2024) |
| GlaxoSmithKline, LLC. | $974.18 | 17 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $815.79 | 35 | $0 (2024) |
| Amgen Inc. | $617.50 | 22 | $0 (2024) |
| OPKO Pharmaceuticals, LLC | $507.75 | 46 | $0 (2023) |
| Eli Lilly and Company | $488.80 | 1 | $0 (2024) |
| Outset Medical Inc | $398.64 | 6 | $0 (2024) |
| Otsuka America Pharmaceutical, Inc. | $398.58 | 20 | $0 (2024) |
| Aurinia Pharma U.S., Inc. | $380.49 | 10 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $5,759 | 72 | CSL Behring ($2,066) |
| 2023 | $1,276 | 63 | AstraZeneca Pharmaceuticals LP ($166.90) |
| 2022 | $1,069 | 46 | AstraZeneca Pharmaceuticals LP ($246.00) |
| 2021 | $658.19 | 33 | AstraZeneca Pharmaceuticals LP ($120.10) |
| 2020 | $215.48 | 13 | Horizon Therapeutics plc ($70.59) |
| 2019 | $387.96 | 18 | Philips Electronics North America Corporation ($114.49) |
| 2018 | $1,168 | 32 | GlaxoSmithKline, LLC. ($792.75) |
| 2017 | $417.70 | 14 | Amgen Inc. ($154.69) |
All Payment Transactions
291 individual payment records from CMS Open Payments — Page 1 of 12
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/21/2024 | Amgen Inc. | KRYSTEXXA (Biological) | Food and Beverage | In-kind items and services | $20.80 | General |
| Category: Inflammation/Rare Disease | ||||||
| 11/20/2024 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $16.36 | General |
| Category: Bone Health | ||||||
| 11/15/2024 | Travere Therapeutics, Inc. | — | Food and Beverage | In-kind items and services | $14.67 | General |
| 11/07/2024 | Mallinckrodt Hospital Products Inc. | ACTHAR (Biological) | Food and Beverage | In-kind items and services | $22.80 | General |
| Category: IMMUNOLOGY | ||||||
| 11/06/2024 | Aurinia Pharma U.S., Inc. | LUPKYNIS (Drug) | Food and Beverage | In-kind items and services | $26.77 | General |
| Category: LUPUS NEPHRITIS | ||||||
| 10/10/2024 | Mallinckrodt Hospital Products Inc. | ACTHAR (Biological) | Food and Beverage | In-kind items and services | $21.34 | General |
| Category: IMMUNOLOGY | ||||||
| 09/30/2024 | Aurinia Pharma U.S., Inc. | LUPKYNIS (Drug) | Food and Beverage | In-kind items and services | $29.12 | General |
| Category: LUPUS NEPHRITIS | ||||||
| 09/23/2024 | Otsuka America Pharmaceutical, Inc. | JYNARQUE (Drug) | Food and Beverage | In-kind items and services | $29.33 | General |
| Category: NEPHROLOGY | ||||||
| 09/18/2024 | Amgen Inc. | KRYSTEXXA (Biological) | Food and Beverage | In-kind items and services | $24.81 | General |
| Category: Inflammation/Rare Disease | ||||||
| 09/10/2024 | ANI Pharmaceuticals, Inc. | PURIFIED CORTROPHIN GEL (Drug) | Food and Beverage | In-kind items and services | $19.08 | General |
| Category: Treatment of certain chronic autoimmune disorders including acute exacerbations of MS and RA | ||||||
| 09/09/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $27.59 | General |
| Category: Cardio-renal | ||||||
| 09/02/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $24.27 | General |
| Category: Diabetes Care | ||||||
| 08/27/2024 | Amgen Inc. | KRYSTEXXA (Biological) | Food and Beverage | In-kind items and services | $2.46 | General |
| Category: Inflammation/Rare Disease | ||||||
| 08/26/2024 | ANI Pharmaceuticals, Inc. | PURIFIED CORTROPHIN GEL (Drug) | Food and Beverage | In-kind items and services | $23.67 | General |
| Category: Treatment of certain chronic autoimmune disorders including acute exacerbations of MS and RA | ||||||
| 08/21/2024 | CorMedix Inc. | DefenCath (Drug) | Food and Beverage | In-kind items and services | $36.19 | General |
| Category: Catheter Lock Solution | ||||||
| 08/19/2024 | Amgen Inc. | KRYSTEXXA (Biological) | Food and Beverage | In-kind items and services | $23.16 | General |
| Category: Inflammation/Rare Disease | ||||||
| 08/18/2024 | Eli Lilly and Company | — | Travel and Lodging | In-kind items and services | $488.80 | General |
| 08/13/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $13.47 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 08/07/2024 | Lilly USA, LLC | JARDIANCE (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $6.30 | General |
| Category: Diabetes | ||||||
| 07/22/2024 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $14.22 | General |
| Category: Bone Health | ||||||
| 07/16/2024 | Mallinckrodt Hospital Products Inc. | ACTHAR (Biological) | Food and Beverage | In-kind items and services | $21.46 | General |
| Category: IMMUNOLOGY | ||||||
| 07/15/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $18.94 | General |
| Category: Cardio-renal | ||||||
| 06/27/2024 | Outset Medical Inc | — | Food and Beverage | In-kind items and services | $142.96 | General |
| 06/25/2024 | Medtronic, Inc. | ELLIPSYS VASCULAR ACCESS SYSTEM (Device) | Travel and Lodging | In-kind items and services | $78.95 | General |
| Category: Catheters | ||||||
| 06/24/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $25.00 | General |
| Category: Cardio-renal | ||||||
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| A PHASE 3 RANDOMIZED, DOUBLE-BLIND, ACTIVE-CONTROLLED, PARALLEL-GROUP, | GlaxoSmithKline, LLC. | $792.75 | 5 |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 36 | 1,358 | 5,091 | $851,162 | $335,318 |
| 2022 | 31 | 1,757 | 6,905 | $949,628 | $356,868 |
| 2021 | 40 | 2,018 | 8,764 | $2.0M | $603,726 |
| 2020 | 49 | 2,566 | 12,068 | $2.7M | $722,171 |
Total Patients
7,699
Total Services
32,828
Medicare Billing
$2.0M
Procedure Codes
156
All Medicare Procedures & Services
156 procedure records from CMS Medicare Utilization — Page 1 of 7
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 177 | 811 | $199,878 | $77,792 | 38.9% |
| 90960 | Dialysis services, 4 or more physician visits per month (20 years or older) | Office | 2023 | 39 | 219 | $106,001 | $58,463 | 55.2% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 94 | 754 | $124,562 | $46,390 | 37.2% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 90 | 272 | $64,288 | $25,006 | 38.9% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 99 | 145 | $53,480 | $19,437 | 36.3% |
| 90961 | Dialysis services, 2-3 physician visits per month (20 years or older) | Office | 2023 | 30 | 63 | $31,890 | $14,357 | 45.0% |
| 37252 | Ultrasound evaluation of blood vessel with review by radiologist, initial vessel | Office | 2023 | 12 | 18 | $55,125 | $13,369 | 24.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 87 | 180 | $30,047 | $12,237 | 40.7% |
| 99496 | Transitional care management services for problem of high complexity | Office | 2023 | 34 | 46 | $24,296 | $9,669 | 39.8% |
| 99490 | Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 64 | 202 | $23,563 | $9,538 | 40.5% |
| 90966 | Home dialysis services per month (20 years or older) | Office | 2023 | 11 | 43 | $17,161 | $8,258 | 48.1% |
| 90935 | Hemodialysis procedure with physician evaluation | Facility | 2023 | 27 | 116 | $16,541 | $6,496 | 39.3% |
| 99458 | Management using the results of remote vital sign monitoring per calendar month, each additional 20 minutes | Office | 2023 | 48 | 139 | $13,150 | $4,287 | 32.6% |
| 76770 | Complete ultrasound scan behind abdominal cavity | Office | 2023 | 47 | 48 | $14,200 | $3,687 | 26.0% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 28 | 28 | $9,204 | $3,378 | 36.7% |
| 99457 | Management using the results of remote vital sign monitoring per calendar month, first 20 minutes | Office | 2023 | 49 | 74 | $9,620 | $2,798 | 29.1% |
| 99495 | Transitional care management services for problem of at least moderate complexity | Office | 2023 | 17 | 17 | $6,336 | $2,550 | 40.2% |
| 99484 | Care management services for behavioral health conditions, 20 minutes or more clinical staff time directed by health care professional | Office | 2023 | 49 | 74 | $8,370 | $2,474 | 29.6% |
| 99231 | Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes | Facility | 2023 | 29 | 63 | $5,498 | $2,446 | 44.5% |
| 90962 | Dialysis services, 1 physician visit per month (20 years or older) | Office | 2023 | 11 | 15 | $5,043 | $2,365 | 46.9% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 12 | 13 | $4,078 | $1,603 | 39.3% |
| 97110 | Therapy procedure using exercise to develop strength, endurance, range of motion, and flexibility, each 15 minutes | Office | 2023 | 11 | 66 | $4,752 | $1,531 | 32.2% |
| 97162 | Evaluation for physical therapy, typically 30 minutes | Office | 2023 | 17 | 18 | $3,564 | $1,429 | 40.1% |
| 99454 | Remote monitoring of physiologic parameters, initial supply of devices with daily recordings or programmed alerts transmission, each 30 days | Office | 2023 | 22 | 27 | $2,430 | $1,031 | 42.4% |
| 95923 | Testing of autonomic (sympathetic) nervous system function | Office | 2023 | 11 | 12 | $2,892 | $1,016 | 35.1% |
About Dr. Robert Szewc, MD
Dr. Robert Szewc, MD is a Nephrology healthcare provider based in San Antonio, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/20/2006. The National Provider Identifier (NPI) number assigned to this provider is 1992759476.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Robert Szewc, MD has received a total of $10,950 in payments from pharmaceutical and medical device companies, with $5,759 received in 2024. These payments were reported across 291 transactions from 38 companies. The most common payment nature is "Food and Beverage" ($6,659).
As a Medicare-enrolled provider, Szewc has provided services to 7,699 Medicare beneficiaries, totaling 32,828 services with total Medicare billing of $2.0M. Data is available for 4 years (2020–2023), covering 156 distinct procedure/service records.
Ad
Practice Information
- Specialty Nephrology
- Location San Antonio, TX
- Active Since 05/20/2006
- Last Updated 12/23/2021
- Taxonomy Code 207RN0300X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1992759476
Products in Payments
- ELLIPSYS VASCULAR ACCESS SYSTEM (Device) $1,741
- KRYSTEXXA (Biological) $464.11
- LOKELMA (Drug) $438.68
- LUPKYNIS (Drug) $380.49
- JYNARQUE (Drug) $363.60
- FARXIGA (Drug) $359.34
- ACTHAR (Biological) $311.89
- RAYALDEE (Drug) $287.87
- Rayaldee (Drug) $210.44
- Kerendia (Drug) $201.76
- SOLIRIS (Biological) $180.95
- EVENITY (Biological) $180.75
- Auryxia (Drug) $159.19
- BENLYSTA (Biological) $127.56
- Parsabiv (Biological) $123.71
- CVX-300CVX-300P (Device) $114.74
- IGT Devices Und (Device) $114.49
- Ozempic (Drug) $107.64
- (9520) IGT Devices Undivided (Device) $99.67
- PREVNAR 13 (Biological) $92.58
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Nephrology Doctors in San Antonio
Dr. Pablo Pergola, Md, MD
Nephrology — Payments: $367,911
Nephrology $367,911
Luis Velez, M.d, M.D
Nephrology — Payments: $328,523
Nephrology $328,523
Dr. Rashid Sharaf, M.d, M.D
Nephrology — Payments: $324,361
Nephrology $324,361
Edward Lazaga, M.d, M.D
Nephrology — Payments: $82,009
Nephrology $82,009
Shweta Bansal, Md, MD
Nephrology — Payments: $51,774
Nephrology $51,774
Dr. Anwar Gerges, Md, MD
Nephrology — Payments: $49,284
Nephrology $49,284